Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dementia01:30

Dementia

526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
526
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Ethical Dilemmas II01:30

Ethical Dilemmas II

2.3K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Data Validation01:03

Data Validation

6.3K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implications.

The Lancet. Neurology·2026
Same author

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases.

Neurology·2026
Same author

Attitudes Towards Brain Health and Dementia Risk Reduction Among Minoritised Ethnic Communities in the United Kingdom: A Cross-Sectional Survey Analysis.

International journal of geriatric psychiatry·2026
Same author

Recruitment strategies in a diverse Parkinson's disease cohort: lessons from the East London Parkinson's Disease Project.

BMJ neurology open·2026
Same author

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

相关实验视频

Updated: Jan 18, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K

诺丁汉关于减少痴呆风险政策的共识:修改后的德尔菲进程的建议.

Harriet Demnitz-King1, Sube Banerjee2, Claudia Cooper3

  • 1Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University, London, UK. h.demnitz-king@qmul.ac.uk.

Nature reviews. Neurology
|January 16, 2026
PubMed
概括

制定有效的痴呆风险降低策略需要解决健康不平等问题. 这项研究概述了预防痴呆症的56个可行的政策建议,重点关注公共卫生,个人和人口干预以及研究.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

相关实验视频

Last Updated: Jan 18, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

科学领域:

  • 公共卫生 公共卫生
  • 神经科学是一个神经科学.
  • 卫生政策 卫生政策

背景情况:

  • 将减轻痴呆风险的证据转化为公平的公共卫生政策是一项挑战.
  • 国家卫生和护理研究院痴呆症和神经退行症政策研究部门 (DeNPRU-QM) 解决了这一差距.

研究的目的:

  • 为英国减少痴呆风险制定可行的政策建议.
  • 为其他国家的痴呆症预防策略提供指导.

主要方法:

  • 召集了一个由40名专家组成的多学科小组.
  • 进行了为期两天的研讨会和三轮修改的Delphi调查.
  • 对痴呆症预防和风险降低的评估和改进的陈述.

主要成果:

  • 在四个领域就56项建议达成共识:公共卫生信息,个人干预,人口干预和研究委托.
  • 强调解决健康不平等问题,以防止加剧差距.
  • 强调需要明确的沟通,有针对性的干预和持续的研究投资.

结论:

  • 这些建议为基于证据的痴呆症预防策略提供了基础.
  • 优先考虑公平,解决结构性不平等,对于降低痴呆风险至关重要.
  • 跨部门宣传对于政策的制定和实施至关重要.